Infection and Drug Resistance (Jun 2021)
Trend in Antimicrobial Resistance of Staphylococcus aureus: Results from the China Antimicrobial Surveillance Network (CHINET) in the Last 15-Year-Period Reports (2005–2019)
Abstract
Yingjian Liang,1,* Lidi Qiu,2,* Xiaobin Zheng,1 Jing Liu1 1Department of Pulmonary and Critical Care Medicine (PCCM), The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519000, People’s Republic of China; 2Department of Infectious Disease Intensive Care Unit, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jing Liu; Xiaobin ZhengDepartment of Pulmonary and Critical Care Medicine (PCCM), Fifth Affiliated Hospital of Sun Yat-sen University, 52 East Meihua Road, Zhuhai City, 519000, People’s Republic of ChinaTel/Fax +867562528733Email [email protected]; [email protected]: In this report, we analyze the trends in antimicrobial resistance of Staphylococcus aureus according to the last 15-year-period reports of the China Antimicrobial Surveillance Network (CHINET). It is encouraging that there is a decreasing MRSA proportion in the infection of adults as well as better activity of non-beta-lactam agents in vitro in recent years. However, childhood MRSA infection as well as the tigecycline-resistant MRSA isolate in China deserves increasing concern.Keywords: Staphylococcus aureus, antimicrobial resistance, China Antimicrobial Surveillance Network
